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Studies on effectiveness of cardiac rehabilitation (CR) in elderly cardiovascular disease
patients are rare, and it is unknown, which patients benefit most. We aimed to identify pre-
dictors for 1-year outcomes of cardiorespiratory fitness and CV risk factor (CVRF) control in
patients after completing CR programs offered across seven European countries.
Methods
Cardiovascular disease patients with minimal age 65 years who participated in comprehen-
sive CR were included in this observational study. Peak oxygen uptake (VO2), body mass
index (BMI), resting systolic blood pressure (BPsys), and low-density lipoprotein-cholesterol
(LDL-C) were assessed before CR (T0), at termination of CR (T1), and 12 months after start
of CR (T2). Predictors for changes were identified by multivariate regression models.
Results
Data was available from 1241 out of 1633 EU-CaRE patients. The strongest predictor for
improvement in peak VO2 was open chest surgery, with a nearly four-fold increase in sur-
gery compared to non-surgery patients. In patients after surgery, age, female sex, physical
inactivity and time from index event to T0 were negative predictors for improvement in peak
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VO2. In patients without surgery, previous acute coronary syndrome and higher exercise
capacity at T0 were the only negative predictors. Neither number of attended training ses-
sions nor duration of CR were significantly associated with change in peak VO2. Non-sur-
gery patients were more likely to achieve risk factor targets (BPsys, LDL-C, BMI) than
surgery patients.
Conclusions
In a previously understudied population of elderly CR patients, time between index event
and start of CR in surgery and disease severity in non-surgery patients were the most impor-
tant predictors for long-term improvement of peak VO2. Non-surgery patients had better
CVRF control.
Background
Comprehensive cardiac rehabilitation programmes (CR) have the potential to improve cardio-
respiratory fitness (CRF) [1], cardiovascular risk factors (CVRF) [2], and reduce hospitalisa-
tions and cardiovascular mortality [2–6]. However, long-term CVRF control in patients with
acute and chronic coronary syndromes remains poor across Europe [7]. Studies on short- and
long-term effectiveness of CR generally suffer from underrepresentation of elderly patients,
particularly patients older than 80 years of age.
The mean age of classical CR studies was around 60 to 62 years, and predictors for a lesser
improvement in CRF have been found to be older age, female sex, increased body mass index
(BMI), smoking and presence of diabetes mellitus (DM) [8–10]. Whether the same factors are
responsible for effectiveness in elderly CR patients, has not been investigated so far.
EU-CaRE was a European project focusing on the effectiveness and sustainability of CR
programs in the elderly (65 years or above). The main objective of EU-CaRE was to obtain the
evidence base to improve, tailor and optimise CR programmes regarding sustainable effective-
ness, cost-effectiveness and participation level. EU-CaRE involved eight participating CR sites
in seven countries (Denmark, France, Germany, Italy, the Netherlands, Spain and Switzerland)
[11].
The purpose of the present study was to identify predictors for CR effectiveness in terms of
improvement in CRF and CVRF control, namely goal-directed therapy of low-density-lipo-
protein-cholesterol (LDL-C), blood pressure (BP), weight, and HbA1c in patients with DM.
Depending on the nature of identified predictors, better results by CR may be achieved
through appropriate adaptation of the CR programmes.
Methods
The EU-CaRE observational study compared different CR programmes provided to elderly
cardiac patients at eight European sites in Bern, Copenhagen, Ludwigshafen, Paris, Parma,
Nijmegen, Santiago de Compostela and Zwolle. We aimed at including a total of 1760 patients
equivalent of 220 patients from each site. The CR program offered at each site has been
described previously [12].
Study population
The study population and baseline data have been reported previously [11]. Briefly, elderly (65
+) patients participating in CR of one of the eight European centres after coronary artery
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bypass grafting (CABG), percutaneous coronary intervention (PCI) or without revasculariza-
tion as well as after percutaneous or surgical valve replacement (HVR) were included. Patients
were assessed at baseline before commencing CR (T0), after completing the CR program (T1)
and at 1-year follow-up (T2).
The study was approved by the lead ethics committee (Medisch Ethische Toetsingscommis-
sie at Isala, Netherlands) and all relevant medical ethics committees, registered at trialregister.
nl (NTR5306). The participants gave written informed consent before they were included in
the study.
Data collection
Recorded information included demographics, index event, socioeconomic factors, medical
history including co-morbidity, and clinical information such as weight, blood pressure (BP),
resting heart rate and CRF (cardiopulmonary exercise testing, CPET), medication, and patient
reported outcomes which included physical activity in terms of number of days per week with
at least moderate physical activity of minimally 30 min. Obesity was defined as body mass
index (BMI)�30 kg/m2. Exercise capacity was assessed by CPET. Number of attended train-
ing sessions were monitored at each site, offered sessions ranged from 10 to 36 between sites.
Lag time of CR start was defined as days between revascularisation or valve treatment and CR
entry visit (T0). Date of first diagnosis was used to calculate lag time in stable CAD patients
without surgical or percutaneous intervention. CR duration was defined as days between CR
start (T0) to CR conclusion (T1). Details on the data collected have been provided elsewhere
[11–14].
CPETs were performed on cycle ergometers with spirometry, electrocardiogramme regis-
tration and blood pressure measurement using local certified equipment and a common pro-
tocol according to current recommendations [15]. A warm-up at 5 Watt was performed for 3
min. The ramp protocol was individualized to achieve the optimal test duration of 8–12 min
until exhaustion. We aimed to surpass the anaerobic threshold and a respiratory quotient
(RQ) of>1.1. CPET data was analysed in the CPET core lab in Bern. Peak oxygen uptake
(VO2) was determined from raw data files using MATLAB software from MathWorks1. Gas
measures were excluded from the analysis in case of suspected mask leakage or equipment fail-
ure or if the ramp duration was less than 3 min. In these cases, VO2 was calculated with a for-
mula using the maximum Watt [16].
Outcomes
Predictors were sought for the primary outcome, changes in CRF (T2-T0), namely change in
peak VO2 [ml/kg/min]. Predictors were also sought for secondary outcomes, namely for
CVRF control at T1 and T2, including the achievement of target levels according to current
guidelines [15] as follows: systolic BP (BPsys) < 140 mmHg, LDL-C < 1.8 mmol/l, BMI < 30
kg/m2 (non-obesity) or lowering body weight by� 5%, and HbA1c in diabetic patients < 53
mmol/mol.
Statistical analysis
All statistics were performed with R (Version 3.5.1, R Core Team, 2017).
Robust linear mixed models were performed for change in peak VO2 [ml/min/kg] between
T0 and T2 (function rlmer from package robustlmm version 2.3). The following factors were
included as predictor variables: Age, sex and peak exercise capacity at T0, comorbidities, car-
diovascular risk factors and characteristics of CR, namely, lag time of CR and CR duration and
self-reported physical activity level during follow-up. Centre was entered into the model as a
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random factor. Further, factors from a list of cardiovascular risk factors and comorbidities
(provided in S1 Table) were selected by backward step-wise regression. Non-significant vari-
ables were eliminated from the model manually by individually removing the variable with the
largest p-value until any insignificant (p>0.01) parameters were removed from the model.
This was done to avoid removing non-significant variables which had a large effect on other
significant variables. To adjust at least for some of the multiple testing, alpha was arbitrarily set
at 0.01 for all analyses. The resulting model was also performed with an imputed data set. Miss-
ing values were imputed with multiple imputation (5 imputations, 10 iterations) with predic-
tive mean matching for all variables using the function mice from mice package (v3.4.0).
Logistic regression models were performed using the glmer function of the lme4 package
(v1.1–21) for CVRF control (non-/achievement of target levels) at T1 and T2. CR centres were
included as random factors because we assumed that counselling and education on cardiovas-
cular risk factor treatment may have been important for these variables and were likely to have
differed between centres. The same predictor variables as used for the linear models were
included as fixed factors, except that peak CRF at T0 and reported physical activity at T2 were
omitted because they were not considered relevant, instead, relevant medications were
included.
Results
A total of 1633 patients were included (T0), 1523 (93%) completed the end of CR assessment
(T1), 1457 (89%) the one-year follow-up (T2) and 1429 (88%) attended all three examinations,
as reported previously [13,14,17]. The study flow is shown in Fig 1. For the present study, data
of maximally 1457 patients were included due to missing data in any of the parameters
included into the models. Baseline (pre-CR) characteristics of the study population are shown
in Table 1 split into patients who had an open chest surgery preceding CR and those who had
no intervention or minimally invasive interventions. A detailed description of the primary and
secondary outcomes has been presented previously [17].
Predictors for primary outcome
Since patients with open chest surgery (CABG or surgical HVR) had lower CRF in the first few
days and weeks following surgery but steeper recovery thereafter compared to patients with
only minimally invasive or no procedures (PCI, stable angina or percutaneous HVR patients)
[13,14], we performed the models of the primary outcome for these two populations sepa-
rately. Due to some missing data, 779 non-surgery (including 23 percutaneous HVR) and 469
surgery (including 100 HVR) patients were included. However, this reduced data set was com-
parable to the total data set with regard to change in peak VO2 and age.
Mean increase in peak VO2 from T0 to T2 was 4.4 (SD 3.7) ml/kg/min in surgery and 1.4
(SD 2.3) ml/kg/min in non-surgery patients, whereby values were lower in surgery patients
before CR and comparable to non-surgery patients after one year (Table 1). Results from the
robust mixed linear models for the two split populations (surgery and non-surgery patients)
are presented in Fig 2. The following factors were found to significantly contribute to a lesser
change in peak VO2 between T0 and T2 in the surgery patients: Older age, female sex, weight
gain, physical inactivity at T2 and lag time to CR start. In non-surgery patients, significant fac-
tors were previous ACS (before the index event of this study), weight change, and a lower start-
ing exercise capacity (Fig 2). The largest difference in change in peak VO2 was found between
the surgery and non-surgery groups, with the surgery patients improving 3.06 (99% CI 2.57–
3.55) ml/kg/min more than the non-surgery patients. In the surgery patients, males improved
2.07 (99% CI 1.04–3.10) ml/kg/min more than females. A decade in age reduced the
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improvement in peak VO2 by approximately 1.12 (99% CI -1.86 to -0.04) ml/kg/min, a lag
time to start of CR by an additional 10 days reduced the improvement in peak VO2 by approxi-
mately 0.30 (99% CI -0.55 to -0.04) ml/kg/min, and an additional day per week with 30 min of
at least moderate physical activity at T2 increased the change in peak VO2 by 0.25 (99% CI
0.09–0.41) ml/kg/min in the surgery patients. Amongst the non-surgery patients, a previous
ACS decreased the change in peak VO2 by 0.73 (99% CI -1.37 to -0.10) ml/kg/min, and a
higher exercise capacity at T0 by 1 Watt/kg reduced the change in peak VO2 by 0.67 (99% CI
-1.28 to -0.05) ml/kg/min. A body weight increase by 1 kg reduced the change in peak VO2 rel-
ative to body weight by approximately -0.15 (99% CI -0.23 to -0.06) and -0.18 (99% CI -0.25 to
-0.12) ml/kg/min in surgical and non-surgical patients, respectively. Neither, duration of CR
nor number of attended training sessions had a significant effect in either population. The
same models with the imputed data resulted in very similar effect sizes (S1 Fig).
Secondary endpoints
Deviances of all models were acceptable and all smaller than 1.5 times the degrees of freedom.
Fig 1. Study flow. Analysis refers to primary outcome change in peak VO2 from baseline to 1-year follow-up.
https://doi.org/10.1371/journal.pone.0255472.g001
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BPsys. BPsys remained stable overall between T0 and T1, with 78.9% of patients reach-
ing target BPsys at T0 and 83.6% at T1. Age was the only predictor for a higher proportion
of patients not meeting target BPsys at T1, with a decade reducing the chance of meeting
target BPsys by 43%. At T2, only 73.7% reached target BPsys, at T2 BPsys was higher by a
Table 1. Baseline characteristics of surgery and non-surgery patients.
Parameter Surgery (614) Non-surgery (1019)
Personal characteristics
Female sex (%) 126 (20.5%) 248 (24.3%)
Age[yrs] 72.8±5.1 72.9±5.7
BMI [kg/m2] 26.7±4.0 27.5±4.2
BP systolic [mmHg] 122.2±17.7 126.6±17.0
BP diastolic [mmHg] 72.5±11.0 72.9±9.9
LDL-C [mol/l] 2.17±0.76 2.04±0.70
HbA1c [mmol/mol] 40.2±8.6 42.0±9.0
Index intervention
VHD 133 (21.7%) 33 (3.2%)
CABG 481 (78.3%) 0 (0%)
PCI 0 (0%) 890 (87.3%)
Stable angina 0 (0%) 96 (9.4%)
Cardiovascular risk factors
Smoking 49 (8.0%) 105 (10.3%)
Days with >30 min physical activity 3.9±2.8 3.7±2.8
Previous ACS 81 (13.2%) 223 (22.0%)
Hypertension 428 (69.8%) 678 (66.9%)
Hypercholesteremia 419 (68.4%) 770 (66.7%)
Family history of CVD 239 (39.2%) 255 (25.1%)
Diabetes mellitus 146 (23.8%) 253 (24.8%)
Comorbidities
Nephropathy 43 (7.0%) 81 (8.0%)
Chronic heart failure 22 (3.6%) 20 (2.0%)
Peripheral arterial disease 53 (8.6%) 73 (7.2%)
Atrial fibrillation 49 (8.0%) 65 (6.4%)
Medication
Beta blocker 524 (85.3%) 803 (78.8%)
Statins 500 (81.4%) 960 (94.2%)
ACE/ARB 330 (53.7%) 774 (76.0%)
CR characteristics
Time lag index event-CR start [days] 21 (12, 46)� 32 (18,52)�
Duration of CR [days] 24 (17, 54�) 86 (27, 134)�
Number of attended training sessions 14.2±6.2 16.9±9.3
Peak VO2 at CR start 14.4±4.3 16.9±4.9
Peak VO2 after 1 year 19.1±5.4 18.6±5.4
�Data presented as median (Q1, Q3) due to non-parametric distribution.
ACE/ARB, angiotensin converting enzyme inhibitors/angiotensin II receptor blockers; ACS, acute coronary
syndrome; BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass grafting; CR, cardiac
rehabilitation, CVD, cardiovascular disease; diabetes mellitus; LDL-C, low-density lipoprotein cholesterol; HbA1c,
glycated haemoglobin; PCI, percutaneous coronary intervention; VHD, valvular heart disease; VO2, oxygen uptake.
https://doi.org/10.1371/journal.pone.0255472.t001
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median of 5 mmHg (Q3, Q4: -6, 15 mmHg) compared to T1. Negative predictors for meet-
ing target levels in BPsys at T2 were older age and index open chest surgery, with surgery
patients having an odds ratio of 0.7 for achieving target BPsys compared to non-surgery
patients (Fig 3A).
Weight. BMI remained stable overall between T0 and T1, but increased by a median BMI
of 0.29 kg/m2 (Q3, Q4: -0.33, 0.93 kg/m2) at T2. 23.2% of all patients were obese at T0, while
20.9% were obese at T1 and 23.6% at T2. Eleven patients were obese at T1 but had decreased
their weight from T0 by at least 5%. At T2, there were no obese patients who had decreased
their weight by at least 5% between T1 and T2. As expected, BMI at T0 was strongly predictive
Fig 2. Predictors for change in peak VO2 in the 468 surgery and 773 non-surgery patients. Shown are estimates and 99%
confidence intervals of included parameters from the separate robust linear mixed regression models for change in peak VO2 from T0
to T2 for the two sub-populations. CRF at T0, attended number of training sessions, inactivity, lag time to CR start and duration of CR
were included a priori. The other variables were significant variables in the model for the pooled data but shown here for the surgery
and non-surgery populations separately. Centre was included as random factor. COPD, chronic obstructive pulmonary disease; ACS,
acute coronary syndrome; DM, diabetes mellitus; CR, cardiac rehabilitation.
https://doi.org/10.1371/journal.pone.0255472.g002
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of BMI at T1 and T2. Surgery patients had an odds ratio of approximately 0.3 to reach target
levels of BMI compared to non-surgery patients (Fig 3B).
LCL-C. Amongst the CAD patients (excluding patients with VHD), LDL-C declined from
T0 to T1 by a median of 0.09 mmol/l (Q3, Q4: -0.37, 0.20 mmol/l), with 39.5% reaching target
levels at T0 and 43.4% at T1. Between T1 and T2 there was an increase in LDL-C by a median
of 0.08 mmol/l (Q3, Q4: -0.20, 0.42 mmol/l), with only 35.4% of all patients reaching target lev-
els at T2. At T1, surgery patients had an odds ratio of 0.5 to reach target levels compared to
non-surgery patients, and males had an odds ratio of 1.3 compared to females (Fig 3C).
Patients with DM were 2.0 and 1.6 more likely to reach target LDL-C at T1 and T2, respec-
tively. Patients taking statins had an odds ratio of 4.8 to reach target LDL-C at T1 and T2 com-
pared to those not taking statins (7.1%).
HbA1c in patients with diabetes. HbA1c in patients with DM decreased between T0 and
T1 by 1.0 mmol/mol (Q3, Q4: -4.0, 3.0 mmol/mol) with 62.2% and 66.6% reaching target levels
of<53 mmol/mol at T0 and T1, respectively, and increased from T1 to T2 by a median 1.1
mmol/mol (Q3, Q4: -2.19, 5.47 mmol/mol) with 59.1% reaching target levels at T2. The only
significant predictor for patients reaching target levels was intake of insulin at both time
points, with an odds ratio of 0.24 for reaching target HbA1c in patients taking insulin at T1
and 0.18 at T2 (Fig 3D).
Fig 3. Predictors for reaching target levels of secondary outcome parameters at T1 and T2. Shown are odds ratios and 99% confidence intervals of included parameters
from the logistic mixed regression model for reaching target BPsys (a), target BMI (b), target LDL-C in CAD patients (c), and target HbA1c in diabetic patients (d).
Centres (random factor) are not shown. Number of patients included in the models for T1 and T2 were 1451 and 1305 for BPsys, 1455 and 1311 for BMI, 1203 and 1058
for LDL-C (excluding VHD patients), and 314 and 280 for HbA1c in diabetic patients. BMI, body mass index; DM, diabetes mellitus; COPD, chronic obstructive
pulmonary disease; ACS, acute coronary syndrome; CR, cardiac rehabilitation.
https://doi.org/10.1371/journal.pone.0255472.g003
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Discussion
The main predictor for sustainable effectiveness of the primary outcome peak VO2 was index
intervention, with patients with open chest surgery starting at lower peak VO2 values than
those with no or only percutaneous procedures but reaching comparable values at 1-year fol-
low-up [13]. In non-surgery patients, advanced disease with previous ACS, weight increase,
and a higher exercise capacity at baseline were the only predictors for a lesser improvement in
peak VO2, while in surgery patients, female sex, older age, greater lag time, physical inactivity
and weight increase were negative predictors. Non-surgery patients had better outcomes with
regard to BPsys and LDL-C than surgery patients. Male CAD patients and patients with DM
had better outcomes with regard to LDL-C.
Primary outcome
We observed only small changes in peak VO2 in non-surgery patients of 1/3 metabolic equiva-
lent (MET), with weight change, previous ACS, and exercise capacity at T0 being significant
predictors. The effect of weight change was due to the relative unit of CRF in VO2 per body
mass. Previous ACS can be taken as synonymous with more advanced disease progression.
The inverse relationship between exercise capacity at baseline and increase in peak VO2 during
CR may be partly due to patients with lower fitness having a greater potential to improve, and
partly due to a phenomenon termed “regression towards the mean” [18].
In surgery patients, on the other hand, changes in peak VO2 between T0 and T2 were just
over 1 MET due to lower peak VO2 at T0 but comparable values at T2 compared to non-sur-
gery patients. In our patients, mean improvement in peak VO2 of surgery patients was almost
4-fold the improvement of non-surgery patients. As mentioned in two previous studies, the
reason for this may be lower levels of CRF of surgery patients due to bedrest and surgery-
related restrictions in ventilation [19,20]. In fact, a randomized training study in CABG
patients found the same improvement in peak VO2 in the exercise and control groups, indicat-
ing that recovery takes place also in the absence of a structured exercise-based CR programme
[21]. Significant predictors for worse outcome in the surgery patients were older age, female
sex, inactivity at T2 and lag time to start of CR. An additional decade in age was related to a
reduced recovery in peak VO2 by 1.1 ml/kg/min, while in non-surgery patients the reduction
was only 0.4 ml/kg/min, suggesting that older age may not only reduce the effect of a physical
training stimulus but also have an adverse effect on the healing process from surgery [22]. A
previous study on patients undergoing CR has found older age to be a negative predictor for
improvement in CRF [9], and another study found a smaller increase in CRF in elderly com-
pared to younger patients [23]. However, other studies have found similar or even greater
improvements in peak VO2 with increasing age [24]. The level of physical activity at 1-year fol-
low-up was positively associated with increase in peak VO2 in our surgery patients. While our
data is inconclusive with regard to the direction of a potentially causal relationship, CR has
been found to increase physical activity compared to control treatments [25].
Lag time to CR start was inversely related to change in peak VO2 whereby the relationship
was exponential rather than linear [13]. Surgery patients who started CR within the first 30
days after surgery had a mean increase in peak VO2 of 5.5±3.9 ml/kg/min (congruent with a
lower starting peak VO2), while those starting after 30 days only had a mean increase of 2.9
±3.2 ml/kg/min, and from 60 days onward it stabilized at 1.7±2.7 ml/kg/min, which was simi-
lar to the improvement of non-surgery patients. It is unlikely that patients benefited less from
CR if they started CR late after surgery, rather, a late start with CR did not coincide with the
steepest recovery process early after surgery. When controlled for lag time, duration of the
exercise programme, on the other hand, was not associated with change in peak VO2, this is
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remarkable given the fact that prescribed programmes ranged from 2 to 36 weeks. A similar
conclusion was drawn by a recent meta-regression analysis, which found exercise intervention
intensity to be the only predictive factor for the difference in CRF between randomized exer-
cise-based CR and control groups [26]. Training intensity was monitored in a subset of
patients and its influence on change in peak VO2 was reported elsewhere [27].
A surprising result of the present study was the much smaller increase in peak VO2 in the
75 female surgery patients compared to the 393 surgery male patients after the multivariate
adjustment. Recovery in physical function [28] and wound healing has been found impeded in
female CABG patients compared to males [29]. We cannot exclude that indications for CABG
and/or surgical valve replacement were different for male and female patients.
The effect of DM has been addressed in a separate publication [13].
Secondary outcomes
Target values for BPsys were less likely to be reached by surgery patients and the odds for
reaching target were approximately 30% lower for each additional decade higher age.
Regarding BMI, again surgery patients had a smaller odds ratio for reaching BMI target at
both time points. Additionally, a decade of higher age was related to a two-fold higher odds
ratio of reaching these BMI targets. With 24% obesity, the proportion of obese patients was
considerably lower in our elderly population compared to the documented 38% obese patients
in the EUROASPIRE population with a mean age of 63 years [7].
Male CAD patients and CAD patients with DM were more likely to achieve LDL-C target
values, possibly because dyslipidemia was treated more aggressively in these latter patients.
The previously documented acute drop in LDL-C after acute myocardial infarction [30] or car-
diac surgery [31] with subsequent recovery may explain the odds ratio of 0.5 for surgery
patients to reach LDL-C target levels at T1. A small percentage (7.3%) of our CAD patients
was not on statins.
Strengths and limitations
The main strength of the study is the inclusion of a large and heterogenous elderly patient pop-
ulation of seven European countries, reflecting daily practice of these centres. A further
strength is the available data on the heterogenous lag times to start of the CR programme,
which in elderly surgery patients seems to be the main determinant for improvement in CRF.
One of the main limitations is that lag time after event to start of CR and CR duration were
not independent of centres, therefore the predictive effects of these time variables may be
under- or overestimated due to additional specific CR programme or cultural/ethnic effects.
In elderly people, it is difficult to achieve maximal CPETs due to many physical ailments
such as orthopedic disabilities. However, when the model for primary outcome was adjusted
for change in respiratory exchange ratio (a parameter commonly used for level of achieved
exhaustion), effects remained comparable.
The patients lost to follow-up (T2) had with 13.8 (95% CI 13.3–14.3) ml/kg/min a signifi-
cantly lower baseline peak VO2 than patients completing follow-up with 16.4 (95% CI 16.3–
16.6) ml/kg/min. Therefore, our results may be more applicable to fitter patients.
Conclusion
The present study revealed specific predictors for clinically relevant 1-year outcomes in an
elderly CR population, an understudied patient group. It demonstrated a large difference in
the recovery process between patients with and without open chest surgery. Older age and
female sex were associated with poorer recovery in peak VO2 in surgery patients. Neither
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length of the CR program nor the number of CR training sessions were associated with long-
term improvement of CRF while levels of physical activity at T2 were relevant. CVRF control
was better in non-surgery patients. This highlights the importance of individualized physical
activity counselling and CVRF management in comprehensive CR [32].
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